Rocket


News + Filings
Transactions





James Steven P

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/25/2023Allakos Inc.ALLKGrantStock Option (Right to buy)86.8k$4.81$417.3k 05/25/2023
05/25/2022Allakos Inc.ALLKGrantStock Option (Right to buy)99.6k$2.62$260.9k 05/25/2022
09/28/2021Allakos Inc.ALLKExerciseStock Option (Right to buy)4k$0.53$2.1k 09/28/2021
09/28/2021Allakos Inc.ALLKSaleCommon Stock4k$108.12$432.5k 09/28/2021
05/25/2021Allakos Inc.ALLKGrantStock Option (Right to buy)7.7k$99.83$768.7k 05/25/2021
03/16/2021Allakos Inc.ALLKExerciseStock Option (Right to buy)3.5k$0.53$1.8k 03/16/2021
03/16/2021Allakos Inc.ALLKSaleCommon Stock3.5k$121.65$425.8k 03/16/2021
05/26/2020Allakos Inc.ALLKGrantStock Option (Right to Buy)7.7k$72.54$558.6k 05/26/2020
06/06/2019Allakos Inc.ALLKGrantStock Option (Right to Buy)16k$40.00$640k 06/06/2019
03/09/2018Cascadian Therapeutics, Inc.CASCDispositionRestricted Stock Units13.9k$0.00$0 03/09/2018
03/09/2018Cascadian Therapeutics, Inc.CASCOtherCommon Stock13.7k$0.00$0 03/09/2018
12/11/2017Ocera Therapeutics, Inc.OCRXDispositionCommon Stock12.5k$1.52$19k 12/11/2017
12/11/2017Ocera Therapeutics, Inc.OCRXDispositionStock Option (Right to Buy)20k$5.51$110.2k 12/11/2017
12/11/2017Ocera Therapeutics, Inc.OCRXDispositionStock Option (Right to Buy)10k$3.76$37.6k 12/11/2017
12/11/2017Ocera Therapeutics, Inc.OCRXDispositionStock Option (Right to Buy)12.5k$2.26$28.2k 12/11/2017
06/24/2017Cascadian Therapeutics, Inc.CASCExerciseRestricted Share Unit (RSU)9.1k$0.00$0 06/24/2017
06/24/2017Cascadian Therapeutics, Inc.CASCPayment of ExerciseCommon Stock2.3k$3.78$8.6k 06/24/2017
06/20/2017Ocera Therapeutics, Inc.OCRXGrantCommon Stock12.5k$0.00$0 06/20/2017
06/12/2017Cascadian Therapeutics, Inc.CASCExerciseRestricted Share Unit (RSU)2.1k$0.00$0 06/09/2017
06/12/2017Cascadian Therapeutics, Inc.CASCPayment of ExerciseCommon Stock537$3.34$1.8k 06/09/2017
06/09/2017Cascadian Therapeutics, Inc.CASCGrantRestricted Share Unit (RSU)13.9k$0.00$0 06/09/2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy